Top 15 Companies in Global Bioabsorbable Stents Market (2024–2035): Expert View by Spherical Insights
RELEASE DATE: Apr 2026 Author: Spherical InsightsRequest Free Sample Speak to Analyst
Description
According to a research report published by Spherical Insights & Consulting, The Global Bioabsorbable Stents Market Size Is Projected To Grow From USD 443.1 Million In 2024 To USD 865.2 Million By 2035, At A CAGR Of 6.27% During The Forecast Period 2024–2035. The market expansion occurs because cardiovascular diseases are becoming more common and people want less invasive medical treatments and bioabsorbable stents which create fewer long-term problems than permanent implants are becoming more common. The market expansion receives additional support through developments in biodegradable technologies which use polymer and metal materials and the rising level of global healthcare financial backing.
Introduction
The bioabsorbable stents market refers to medical devices designed to temporarily support blocked or narrowed arteries which will dissolve in the body after they restore normal blood flow. The stents serve as the primary treatment option for patients with coronary artery disease and peripheral artery disease. In January 2025, the U.S. Food and Drug Administration approved bioresorbable vascular scaffolds for further development by supporting the creation of safer devices which help improve clinical utilization of next-generation products. European regulatory bodies approved advanced biodegradable implants as medical devices which will help expand market opportunities.
India performs angioplasty at a high frequency because about 4.5 lakh patients receive the treatment each year, which creates a substantial market opportunity for innovative stent products. The market expansion is driven by increasing government support for innovative medical technologies and rising healthcare expenditure and the global shift toward safer and more effective cardiovascular treatments. The development of advanced biodegradable materials together with increasing research and development investments will create long-term growth opportunities.
Navigate Future Markets with Confidence: Insights from Spherical Insights LLP
The insights presented in this blog are derived from comprehensive market research conducted by Spherical Insights LLP, a trusted advisory partner to leading global enterprises. Backed by in-depth data analysis, expert forecasting, and industry-specific intelligence, our reports empower decision-makers to identify strategic growth opportunities in fast-evolving sectors. Clients seeking detailed market segmentation, competitive landscapes, regional outlooks, and future investment trends will find immense value in the full report. By leveraging our research, businesses can make informed decisions, gain a competitive edge, and stay ahead in the transition toward sustainable and profitable solutions.
Unlock exclusive market insights—Download the Brochure now and dive deeper into the future of the Bioabsorbable Stents Market.
Bioabsorbable Stents Market Size & Statistics
- The Market Size for Bioabsorbable Stents Was Estimated to be worth USD 443.1Million in 2024.
- The Market is Going to Expand at a CAGR of 6.27% between 2024 and 2035.
- The Global Bioabsorbable Stents Market Size is anticipated to reach USD 865.2 Million by 2035.
- North America is expected to generate the largest demand during the forecast period in the Bioabsorbable Stents Market.
- Asia Pacific is expected to grow the fastest during the forecast period in the Bioabsorbable Stents Market.
Market Segmentation:
Global Bioabsorbable Stents Market Size, Share, By Biomaterials (Polymer-based Bioabsorbable Stents and Metal-based Bioabsorbable Stents), By Application (Coronary Artery Disease and Peripheral Artery Disease), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 – 2035
Regional growth and demand
Asia-Pacific is expected to grow the fastest during the forecast period in the bioabsorbable stents market. In March 2025, China increased investments in medical device innovation, supporting bioabsorbable stent development. In July 2024, India expanded healthcare infrastructure and cardiac care facilities, boosting demand for advanced stents. The Asia Pacific region is experiencing rapid growth due to increasing healthcare expenditure, rising patient population, and improving access to advanced cardiovascular treatments. The Asia Pacific region dominated the bioabsorbable stents market due to a rapidly aging population, rising incidences of lifestyle-related coronary artery diseases, and surging healthcare expenditure.
North America is expected to generate the largest demand during the forecast period in the bioabsorbable stents market. In October 2024, the U.S. FDA encouraged development of next-generation bioresorbable stents to improve cardiovascular treatment outcomes. In January 2025, major U.S.-based medical device companies expanded R&D investments in biodegradable stent technologies. The North America region dominates the bioabsorbable stents market due to strong healthcare infrastructure, high adoption of advanced medical devices, and increasing prevalence of cardiovascular diseases. North America functions as the primary market for bioabsorbable stents because of its high cardiovascular disease (CVD) rates and growing elderly population and advanced medical facilities.
Ready to lead the Bioabsorbable Stents Market?
Discover the regional trends and growth factors shaping the industry. We’re here to assist with expert, personalized data.
Call +1 303 800 4326 or Send us a message for a personalized consultation.
Top 10 trends in the Bioabsorbable Stents Market
- Rising adoption of biodegradable medical devices
- Growing prevalence of cardiovascular diseases
- Advancements in polymer and magnesium technologies
- Shift toward minimally invasive procedures
- Increasing focus on leave-nothing-behind approach
- Expansion of applications beyond coronary arteries
- Rising investments in research and development
- Integration of imaging and AI technologies
- Regulatory support for innovative medical devices
- Increasing demand in emerging markets
- Rising adoption of biodegradable medical devices
The healthcare industry is increasingly adopting bioabsorbable stents as they dissolve after fulfilling their function, reducing long-term complications and improving patient safety compared to permanent metallic stents.
- Growing prevalence of cardiovascular diseases
The increasing incidence of heart diseases globally is driving demand for advanced treatment solutions such as bioabsorbable stents to improve patient outcomes and reduce mortality rates.
- Advancements in polymer and magnesium technologies
Technological innovations are improving the strength, flexibility, and degradation rates of bioabsorbable stents, enhancing their clinical performance and safety.
- Shift toward minimally invasive procedures
Patients and healthcare providers prefer minimally invasive procedures, increasing demand for stents that reduce recovery time, hospital stays, and surgical risks.
- Increasing focus on leave-nothing-behind approach
The concept of temporary scaffolding that dissolves after treatment is gaining traction, supporting innovation and adoption of bioabsorbable stents globally.
Empower your strategic planning:
Stay informed with the latest industry insights and market trends to identify new opportunities and drive growth in the bioabsorbable stents market. To explore more in-depth trends, insights, and forecasts, please refer to our detailed report.
Unlock exclusive market insights—Download the Brochure now and dive deeper into the future of the Bioabsorbable Stents Market.
Top 15 Companies Leading the Bioabsorbable Stents Market
- Abbott Laboratories
- Biotronik SE & Co. KG
- Boston Scientific Corporation
- Medtronic plc
- Terumo Corporation
- Kyoto Medical Planning Co., Ltd.
- Reva Medical, Inc.
- Elixir Medical Corporation
- Amaranth Medical Inc.
- Meril Life Sciences Pvt. Ltd.
- Arterius Limited
- Xenogenics Corporation
- B. Braun Melsungen AG
- MicroPort Scientific Corporation
- Cook Medical
- Abbott Laboratories
Headquarters: Abbott Park, United States
Abbott Laboratories, founded in 1888 by Wallace Calvin Abbott, is headquartered in Abbott Park, United States. As of 2025, the company generated over USD 40 billion in revenue and employs more than 114,000 people globally, operating in over 160 countries. Abbott is a leader in cardiovascular devices, including bioresorbable vascular scaffolds such as Absorb. The company focuses on innovative medical technologies for heart disease treatment. Its major projects include development of next-generation bioabsorbable stents, expanding clinical trials, and improving device safety and performance to enhance patient outcomes in global cardiovascular care markets.
- Biotronik SE & Co. KG
Headquarters: Berlin, Germany
Biotronik SE & Co. KG, founded in 1963 by Max Schaldach, is headquartered in Berlin, Germany. The company employs approximately 9,000 people globally and operates in over 100 countries. As of 2025, it generated an estimated revenue of around USD 1.5 billion. Biotronik specializes in cardiovascular medical devices, including bioresorbable stents and drug-eluting technologies. Its focus is on innovative and patient-centric solutions for cardiac care. The company’s major projects include advancing biodegradable stent technologies, expanding global clinical studies, and enhancing product portfolios to improve treatment outcomes in interventional cardiology worldwide.
- Boston Scientific Corporation
Headquarters: Marlborough, United States
Boston Scientific Corporation, founded in 1979 by John Abele and Pete Nicholas, is headquartered in Marlborough, United States. As of 2025, the company generated over USD 14 billion in revenue and employs approximately 45,000 people globally, operating in more than 120 countries. Boston Scientific develops innovative medical devices, including bioabsorbable and drug-eluting stents. The company focuses on minimally invasive therapies for cardiovascular diseases. Its major projects include expanding R&D in biodegradable stents, enhancing product innovation, and strengthening global distribution networks to support advanced cardiac treatment solutions.
- Medtronic plc
Headquarters: Dublin, Ireland
Medtronic plc, founded in 1949 by Earl Bakken and Palmer Hermundslie, is headquartered in Dublin, Ireland. As of 2025, the company generated approximately USD 32 billion in revenue and employs over 95,000 people globally, operating in more than 150 countries. Medtronic is a global leader in medical technology, including cardiovascular devices and advanced stent systems. The company focuses on improving patient outcomes through innovation. Its major projects include development of next-generation bioresorbable stents, investment in clinical research, and expansion of minimally invasive treatment solutions across global healthcare markets.
- Terumo Corporation
Headquarters: Tokyo, Japan
Terumo Corporation, founded in 1921 by Kitasato Shibasaburo, is headquartered in Tokyo, Japan. As of 2025, the company generated over USD 6 billion in revenue and employs approximately 30,000 people globally, operating in more than 160 countries. Terumo specializes in medical devices, including cardiovascular and interventional systems such as bioabsorbable stents. The company focuses on innovation in minimally invasive therapies. Its major projects include advancing biodegradable stent technologies, expanding manufacturing capabilities, and strengthening its global presence in cardiovascular treatment markets.
Are you ready to discover more about the bioabsorbable stents market?
The report provides an in-depth analysis of the leading companies operating in the global Bioabsorbable Stents market. It includes a comparative assessment based on their product portfolios, business overviews, geographical footprint, strategic initiatives, market segment share, and SWOT analysis. Each company is profiled using a standardized format that includes:
Company Profiles
- Abbott Laboratories
- Business Overview
- Company Snapshot
- Products Overview
- Company Market Share Analysis
- Company Coverage Portfolio
- Financial Analysis
- Recent Developments
- Merger and Acquisitions
- SWOT Analysis
- Biotronik SE & Co. KG
- Boston Scientific Corporation
- Medtronic plc
- Terumo Corporation
- Kyoto Medical Planning Co., Ltd.
- Reva Medical, Inc.
- Elixir Medical Corporation
- Amaranth Medical Inc.
- Others
Conclusion
The bioabsorbable stents market will experience continuous growth until 2035 because of increasing cardiovascular disease rates and rising demand for safer and less invasive medical treatments. The development of new technologies for biodegradable polymers and metal-based stents leads to better clinical results which medical professionals now use more frequently. The market expands because of strong regulatory backing and the development of healthcare facilities and the rise in research and development funding. North America maintains its position as the top market because of its developed healthcare systems while Asia-Pacific grows at the highest rate because of its rising patient numbers and healthcare expenditures. To remain competitive in the market, major industry companies are prioritizing innovative product development and international business partnerships. The market provides major opportunities for stakeholders who want to benefit from advancements in cardiovascular treatment technologies.
Our Reports:
https://www.sphericalinsights.com/reports/autologous-cell-therapy-market
https://www.sphericalinsights.com/reports/benchtop-tangential-flow-filtration-tff-systems-market
https://www.sphericalinsights.com/reports/blockchain-in-telecom-market
https://www.sphericalinsights.com/reports/board-games-and-puzzles-market
https://www.sphericalinsights.com/reports/broadband-network-gateway-market
https://www.sphericalinsights.com/reports/bulk-drug-intermediates-market
About the Spherical Insights & Consulting
Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.
Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.
CONTACT US:
For More Information on Your Target Market, Please Contact Us Below:
Phone: +1 303 800 4326 (the U.S.)
Phone: +91 90289 24100 (APAC)
Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com
Contact Us: https://www.sphericalinsights.com/contact-us
Need help to buy this report?